Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension, Attenuates Plasma Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin II Infused Mice.
Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension, Attenuates Plasma Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin II Infused Mice.
复制标题
DOI:
10.1155/2012/645969
复制
发表时间:
2012
期刊:
影响因子:
2.9
通讯作者:
Lee DL
中科院分区:
文献类型:
--
作者:
Wilson JL;Duan R;El-Marakby A;Alhashim A;Lee DL
The anti-inflammatory properties of PPAR-α plays an important role in attenuating hypertension. The current study determines the anti-hypertensive and anti-inflammatory role of PPAR-α agonist during a slow-pressor dose of Ang II (400 ng/kg/min). Ten to twelve week old male PPAR-α KO mice and their WT controls were implanted with telemetry devices and infused with Ang II for 12 days. On day 12 of Ang II infusion, MAP was elevated in PPAR-α KO mice compared to WT (161 ± 4 mmHg versus 145 ± 4 mmHg) and fenofibrate (145 mg/kg/day) reduced MAP in WT + Ang II mice (134 ± 7 mmHg). Plasma IL-6 levels were higher in PPAR-α KO mice on day 12 of Ang II infusion (30 ± 4 versus 8 ± 2 pg/mL) and fenofibrate reduced plasma IL-6 in Ang II-treated WT mice (10 ± 3 pg/mL). Fenofibrate increased renal expression of CYP4A, restored renal CYP2J expression, reduced the elevation in renal ICAM-1, MCP-1 and COX-2 in WT + Ang II mice. Our results demonstrate that activation of PPAR-α attenuates Ang II-induced hypertension through up-regulation of CYP4A and CYP2J and an attenuation of inflammatory markers such as plasma IL-6, renal MCP-1, renal expression of ICAM-1 and COX-2.
登录
查看更多内容
影响因子:
8.3
作者:
Vera, T;Taylor, M;Stec, DE
通讯作者:
Stec, DE
影响因子:
4
作者:
Delerive, P;Fruchart, JC;Staels, B
通讯作者:
Staels, B
影响因子:
64.8
作者:
ISSEMANN, I;GREEN, S
通讯作者:
GREEN, S
影响因子:
8.3
作者:
Williams, JM;Zhao, XY;Pollock, DM
通讯作者:
Pollock, DM
影响因子:
8.3
作者:
Funakoshi, Y;Ichiki, T;Takeshita, A
通讯作者:
Takeshita, A